Disease-A-Month
Volume 53, Issue 8 , Pages 394-416 , August 2007

Silicosis: A Review

References 

  1. Muetterties M, O’Halloran Schwarz L, Wang R. Sandblasters. In:  Greenberg M editors. Occupational, Industrial, and Environmental Toxicology. 2nd ed.. Philadelphia, PA: Mosby; 2003;
  2. American Conference of Governmental Industrial Hygienists. Threshold limit values and biological exposure indices. Cincinnati, OH: American Conference of Governmental Industrial Hygienists (ACGIH); 2002;
  3. Valiante DJ, Schill DP, Rosenman KD, et al. Highway repair: a new silicosis threat. Am J Public Health. 2004;94(5):876–880
  4. Hunter D. The Disease of Occupations. 1962;Little, Brown, Boston, MA.
  5. Jordan J. Hawk’s Nest. West Virginia Historical Society Quarterly. 1998;12(1):1–3
  6. Cherniak M. The Hawk’s Nest Incident: America’s Worst Industrial Disaster. New Haven, CT: Yale University Press; 1986;
  7. Occupational Safety and Health Administration (OSHA). 1218-AB70-2040. Occupational Exposure to Crystalline Silica. OSHA: 2004; http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=UNIFIED_AGENDA&p_id=4189 (June 9, 2004).
  8. National Institute for Occupational Safety and Health (NIOSH). Work-Related Lung Disease Surveillance Report 2002 (Publication No. 2003-111). Cincinnati, OH: National Institute for Occupational Safety and Health; 2003;
  9. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1666–1680
  10. Williamson BJ, Pastiroff S, Cressey G. Piezoelectric properties of quartz and cristobalite airborne particulates as a cause of adverse health effects. Atmos Environ. 2001;35:3539–3542
  11. Castranova V. Signalling pathways controlling the production of inflammatory mediators in response to crystalline silica exposure: role of reactive oxygen/nitrogen species. Free Radic Biol Med. 2004;37(7):916–925
  12. Wiessner JH, Henderson JD, Sohnle PG, et al. The effect of crystal structure on mouse lung inflammation and fibrosis. Am Rev Respir Dis. 1988;138(2):445–450
  13. Zaidi SH, King EJ, Harrison CV, et al. Fibrogenic activity of different forms of free silica; the action of fused silica, quartz, cristobalite, and tridymite on the livers of mice. AMA Arch Ind Health. 1956;13(2):112–121
  14. King EJ, Mohanty GP, Harrison CV, et al. The action of flint of variable size injected at constant weight and constant surface into the lungs of rats. Br J Ind Med. 1953;10(2):76–92
  15. American College of Occupational and Environmental Medicine. Policy and Position Statement: Medical surveillance of workers exposed to crystalline silica. http://www.acoem.org/guidelines/article.asp?ID=82.
  16. U.S. Environmental Protection Agency (EPA). Compilation of Air Pollutant Emission Factors, AP-42. In: 5th ed.. Stationary Point and Area Sources. Vol. 1:Washington, DC: EPA; 1995;
  17. Susi P. In: New abrasive blasting methods needed (OnCenter: the newsletter of the center to protect workers’ rights (CPWR)). 4:2004;p. 3;(1)
  18. Fujimura N. Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med. 2000;6(2):140–144
  19. Dubois CM, Bissonette E, Rola-Pleszczynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor (Autoregulatory role of leukotriene B4). Am Rev Respir Dis. 1989;139(5):1257–1264
  20. Hoffman EO, Lamberty J, Pizzolato P, et al. The ultrastructure of acute silicosis. Arch Pathol. 1973;96(2):104–107
  21. Dalal NS, Shi XL, Vallyathan V. ESR spin trapping and cytotoxicity investigations of freshly fractured quartz: mechanism of acute silicosis. Free Radic Res Commun. 1990;9(3-6):259–266
  22. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis. 1989;140(2):531–554
  23. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med. 2003;34(12):1507–1516
  24. Ding M, Chen F, Shi X, et al. Disease caused by silica: mechanisms of injury and disease development. Int Immunopharmacol. 2002;2(2-3):173–182
  25. Surrat P, Winn W, Brody A. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis. 1977;115:521
  26. Miller BE, Bakewell WE, Katyal SL, et al. Induction of surfactant protein (SP-A) biosynthesis and SP-A mRNA in activated type II cells during acute silicosis in rats. Am J Respir Cell Mol Biol. 1990;3(3):217–226
  27. Oghiso Y, Kubota Y. Enhanced interleukin 1 production by alveolar macrophages and increase in Ia-positive lung cells in silica-exposed rats. Microbiol Immunol. 1986;30(11):1189–1198
  28. Schmidt JA, Oliver CN, Lepe-Zuniga JL, et al. Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1 (A potential role for interleukin 1 in the pathogenesis of silicosis). J Clin Invest. 1984;73(5):1462–1472
  29. Davis GS, Pfeiffer LM, Hemenway DR. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol. 1998;17(2):99–114
  30. Yucesoy B, Vallyathan V, Landsittel DP, et al. Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol. 2001;172(1):75–82
  31. Takemura T, Rom WN, Ferrans VJ, et al. Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particles. Am Rev Respir Dis. 1989;140(6):1674–1685
  32. Bagchi N. What makes silica toxic?. Br J Ind Med. 1992;49(3):163–166
  33. Heppleston AG, Styles JA. Activity of a macrophage factor in collagen formation by silica. Nature. 1967;214(87):521–522
  34. Nagelschmidt G. The relation between lung dust and lung pathology in pneumoconiosis. Br J Ind Med. 1960;17:247–259
  35. King EJ, Mohanty GP, Harrison CV, et al. The action of different forms of pure silica on the lungs of rats. Br J Ind Med. 1953;10(1):9–17
  36. Symanski H. Delayed onset sandstone pneumoconiosis: a case report. Am J Ind Med. 1981;2(2):101–102
  37. Cohen C, Fireman E, Ganor E, et al. Accelerated silicosis with mixed-dust pneumoconiosis in a hard-metal grinder. J Occup Environ Med. 1999;41(6):480–485
  38. Duchange L, Brichet A, Lamblin C, et al. Acute silicosis (Clinical, radiologic, functional, and cytologic characteristics of the broncho-alveolar fluids. Observations of 6 cases). Rev Mal Respir. 1998;15(4):527–534
  39. Banks DE, Morring KL, Boehlecke BA, et al. Silicosis in silica flour workers. Am Rev Respir Dis. 1981;124(4):445–450
  40. Banks DE, Bauer MA, Castellan RM, et al. Silicosis in surface coalmine drillers. Thorax. 1983;38(4):275–278
  41. Castranova V, Kang JH, Ma JK, et al. Effects of Bisbenzylisoquinoline alkaloids on alveolar macrophages: correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicol Appl Pharmacol. 1991;108(2):242–252
  42. Gross BH, Schneider HJ, Proto AV. Eggshell calcification of lymph nodes: an update. AJR Am J Roentgenol. 1980;135(6):1265–1268
  43. Wagner GR, Attfield MD, Parker JE. Chest radiography in dust-exposed miners: promise and problems, potential and imperfections. Occup Med. 1993;8(1):127–141
  44. Begin R, Bergeron D, Samson L. Assessment of silicosis in exposed workers. AJR Am J Roentgenol. 1987;148(3):509–514
  45. Cowie RL. The influence of silicosis on deteriorating lung function in gold miners. Chest. 1998;113(2):340–343
  46. Wang XR, Christiani DC. Respiratory symptoms and functional status in workers exposed to silica, asbestos, and coal mine dusts. J Occup Environ Med. 2000;42(11):1076–1084
  47. ILO (International Labor Office). Classification of radiographs of the pneumoconiosis. ME Rad Photogr. 1981;57(1):2–17
  48. International Labor Office. Guidelines for the use of the ILO International Classification of radiographs of Pneumoconiosis. Revised Edition 2000. International labor Organization, Geneva, Switzerland.
  49. Banks DE, Cheng YH, Weber SL, et al. Strategies for the treatment of pneumonconiosis. Occup Med. 1993;8(1):205–232
  50. Sharma SK, Pane JN, Verma K. Effect of prednisolone treatment in chronic silicosis. Am Rev Respir Dis. 1991;143(4 Pt 1):814–821
  51. Goodman GB, Kaplan PD, Stachura I, et al. Acute silicosis responding to corticosteroid therapy. Chest. 1992;101(2):366–370
  52. Kennedy MC. Aluminium powder inhalations in the treatment of silicosis of pottery workers and pneumonconiosis of coal-miners. Br J Ind Med. 1956;13(2):85–101
  53. Begin R, Masse S, Dufresne A. Further information on aluminium inhalation in silicosis. Occup Environ Med. 1995;52(11):778–780
  54. Chen SY, Lu XR. Clinical studies of the therapeutic effect of kexiping on silicosis. In: Institute of Occupational Medicine. Beijing: CAPM Press; 1970;Proceedings of the Therapeutic Effect of Kexiping on Silicosis
  55. Graham WG. Silicosis. Clin Chest Med. 1992;13(2):253–267
  56. Chang KC, Leung CC, Tam CM. Tuberculosis risk factors in a silicotic cohort in Hong Kong. Int J Tuberc Lung Dis. 2001;5(2):177–184
  57. Chan CK, Leung CC, Tam CM, et al. Lung cancer mortality among a cohort of men in a silicotic register. J Occup Environ Med. 2000;42(1):69–75
  58. Steenland K, Sanderson W. Lung cancer among industrial sand workers exposed to crystalline silica. Am J Epidemiol. 2001;153(7):695–703
  59. International Agency for Research on Cancer (IARC). Silica, crystalline monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 68. Lyon, France: International Agency for Research on Cancer; 1997;
  60. International Agency for Research on Cancer (IARC). Silica, some silicates, coal dust and para-aramid fibrils. In: IARC: IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Vol. 68:Lyon, France: International Agency for Research on Cancer; 1997;
  61. Hessel PA, Gamble JF, Gee JB, et al. Silica, silicosis, and lung cancer: a response to a recent working group report. J Occup Environ Med. 2000;42(7):704–720
  62. Cocco P, Rice CH, Chen JQ, et al. Non-malignant respiratory diseases and lung cancer among Chinese workers exposed to Silica. J Occup Environ Med. 2000;42(6):639–644
  63. Soutar CA, Robertson A, Miller BG, et al. Epidemiological evidence on the carcinogenicity of silica: factors in scientific judgement. Ann Occup Hyg. 2000;44(1):3–14
  64. Brown LM, Gridley G, Olsen JH, et al. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med. 1997;39(7):633–638
  65. Doll NJ, Stankus RP, Hughes J, et al. Immune complexes and autoantibodies in silicosis. J Allergy Clin Immunol. 1981;68(4):281–285
  66. Koeger AC, Lang T, Alcaix D, et al. Silica-associated connective tissue disease (A study of 24 cases). Medicine (Baltimore). 1995;74(5):221–237
  67. McDonald AD, McDonald JC, Rando RJ, et al. Cohort mortality study of North American Industrial Sand Workers (I. Mortality from lung cancer, silicosis and other causes). Ann Occup Hyg. 2001;45(3):193–199
  68. Rapiti E, Sperati A, Miceli M, et al. End stage renal disease among ceramic workers exposed to silica. Occup Environ Med. 1999;56(8):559–561
  69. Goldsmith JR, Goldsmith DF. Fiberglass or silica exposure and increased nephritis or ESRD (end-Stage renal disease). Am J Ind Med. 1993;23(6):873–881
  70. Osorio AM, Thun MJ, Novak RF, et al. Silica and glomerulonephritis: case report and review of the literature. Am J Kidney Dis. 1987;9(3):224–230
  71. Brown HV. The history of industrial hygiene: a review with special reference to silicosis. Am Ind Hyg Assoc J. 1965;26(3):212–226
  72. Oudiz J, Brown JW, Ayer HE, et al. A report on silica exposure levels in United States foundries. Am Ind Hyg Assoc J. 1983;44(5):374–376
  73. National Institute for Occupational Safety and Health (NIOSH). Request for Assistance in Preventing Silicosis and Deaths from Sandblasting: Alert (NIOSH Publication No. 92-102). Washington, DC: U.S. Department of Health and Human Services, U.S. Government Printing Office; 1992;
  74. National Institute for Occupational Safety and Health (NIOSH). Criteria for a Recommended Standard: Occupational Exposure to Crystalline Silica (DHEW Publication 75-120). Washington, DC: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control; 1974;
  75. National Institute for Occupational Safety and Health (NIOSH). Work-Related Lung Disease Surveillance Report 1999 (Publication No. 2000-105). Cincinnati, OH: National Institute for Occupational Safety and Health; 1999;
  76. Centers for Disease Control: Surveillance fir silicosis, 1993—Illinois, Michigan, New Jersey, North Carolina, Ohio, Texas, and Wisconsin. MMWR. 1997;46(No. SS-1):
  77. Occupational Safety and Health Administration (OSHA). National News Release USDL: 96-172. Washington, DC: Occupational Safety and Health Administration; 1996;May 8
  78. Rosenman KD, Reilly MJ, Rice C, et al. Silicosis among foundry workers (Implication for the need to revise the OSHA standard). Am J Epidemiol. 1996;144(9):890–900
  79. Valiante DJ, Rosenman KD. Does silicosis still occur?. JAMA. 1989;262(21):3003–3007

PII: S0011-5029(07)00110-1

doi: 10.1016/j.disamonth.2007.09.020

Disease-A-Month
Volume 53, Issue 8 , Pages 394-416 , August 2007

Article Tools